Talenom’s shares have performed well (+32% in 3M) and a lot of the long-term growth potential is already priced in at 2021E EV/EBIT of 37x, in our view. We expect Talenom to continue growing at double-digits in the coming years, but in 2021 a potential rise in Finnish bankruptcies represents a risk to our estimates.
LÄS MER